Investing.com UK - Financial Markets Worldwide

United Therapeutics Corporation (UTHR)

NASDAQ
Symbol
Exchange
Currency
217.10
-3.31(-1.50%)
-Closed.
Currency in USD
Pre Market
219.20
+2.10(+0.97%)
- Real-time Data
  • Volume:
    554,141
  • Day's Range:
    215.41 - 224.06
  • 52 wk Range:
    158.38 - 245.48

UTHR Overview

Prev. Close
220.41
Day's Range
215.41-224.06
Revenue
1.79B
Open
220.66
52 wk Range
158.38-245.48
EPS
13.96
Volume
554,141
Market Cap
9.88B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
485,898
P/E Ratio
16.78
Beta
0.534
1-Year Change
7.15%
Shares Outstanding
45,516,299
Next Earnings Date
02 Nov 2022
What is your sentiment on United Therapeutics?
or
Market is currently closed. Voting is open during market hours.

United Therapeutics Corporation News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

United Therapeutics Corporation Analysis

United Therapeutics Corporation Company Profile

United Therapeutics Corporation Company Profile

Industry
Biotechnology
Sector
Healthcare
Employees
965
Market
United States

United Therapeutics Corporation is a pharmaceutical company. The Company markets and sells four commercial therapies in the United States to treat ulmonary arterial hypertension (PAH): Tyvaso (treprostinil) Inhalation Solution (Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso has also been approved to treat pulmonary hypertension associated with interstitial lung disease. It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin), which is approved for the treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). It also includes technologies designed supply of transplantable organs and tissues and improves outcomes for transplant recipients through regenerative medicine, three-dimensional (3-D) organ bioprinting, xenotransplantation and ex-vivo lung perfusion.

Read More

Income Statement

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellStrong SellSellBuy
Technical IndicatorsBuyStrong SellStrong SellStrong SellStrong Buy
SummaryNeutralStrong SellStrong SellStrong SellStrong Buy

Trending Stocks

Trending Stocks

Name
Last
High
Low
Chg.
Chg. %
Vol.
Time
SSE
1,798.501,802.001,794.68+10.50+0.59%79.97KLondon
Premier African Minerals
0.36510.3590.359+0.0400+12.12%411.69MLondon
Taylor Wimpey
122.97124.45122.80-0.60-0.48%2.31MLondon
HALEON
257.00273.70254.10-14.60-5.38%12.93MLondon
Rolls-Royce Holdings
85.0485.8884.73+0.03+0.04%5.67MLondon
EasyJet
413.60414.60405.00+6.40+1.57%936.41KLondon
Michelmersh Brick
99.20100.0093.00+5.20+5.53%95.63KLondon
Witan
235.00235.50234.000.000.00%318.48KLondon
Treatt PLC
540.00580.00531.00-263.00-32.75%1.36MLondon
Tullow Oil
50.3052.1549.76-1.70-3.27%2.23MLondon
Ceres Power
676.20688.80661.80+14.20+2.15%145.85KLondon
Atlantic Lithium
38.0839.7037.50+0.90+2.41%2.68MLondon
Eurasia Mining
5.775.775.77+0.25+4.54%4.54MLondon
Manolete Partners
266.20266.20266.20-2.50-0.94%14.52KLondon
Galliford Try
161.20171.60161.20+0.40+0.25%35.76KLondon
  • Vote bullish thanks you
    0
    • uthr is coming up in my filter as a potential buy. what should be the right price to buypls share. I will share my analysis too
      0
      • uthr is coming up in my filter as a potential buy. what is the right price to enter? pls share. I will share my analysis too
        0
        • uthr is coming up in my filter as a potential buy. what is the right price to enter? pls share. I will share my analysis too
          0